208 related articles for article (PubMed ID: 33802591)
21. ABT737 reverses cisplatin resistance by regulating ER-mitochondria Ca2+ signal transduction in human ovarian cancer cells.
Xie Q; Su J; Jiao B; Shen L; Ma L; Qu X; Yu C; Jiang X; Xu Y; Sun L
Int J Oncol; 2016 Dec; 49(6):2507-2519. PubMed ID: 27748803
[TBL] [Abstract][Full Text] [Related]
22. An Experimentally Induced Mutation in the UBA Domain of p62 Changes the Sensitivity of Cisplatin by Up-Regulating HK2 Localisation on the Mitochondria and Increasing Mitophagy in A2780 Ovarian Cancer Cells.
Yu S; Yan X; Tian R; Xu L; Zhao Y; Sun L; Su J
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924293
[TBL] [Abstract][Full Text] [Related]
23. GRP75-faciliated Mitochondria-associated ER Membrane (MAM) Integrity controls Cisplatin-resistance in Ovarian Cancer Patients.
Li J; Qi F; Su H; Zhang C; Zhang Q; Chen Y; Chen P; Su L; Chen Y; Yang Y; Chen Z; Zhang S
Int J Biol Sci; 2022; 18(7):2914-2931. PubMed ID: 35541901
[No Abstract] [Full Text] [Related]
24. Inhibitor of apoptosis proteins (IAPs) mediate collagen type XI alpha 1-driven cisplatin resistance in ovarian cancer.
Rada M; Nallanthighal S; Cha J; Ryan K; Sage J; Eldred C; Ullo M; Orsulic S; Cheon DJ
Oncogene; 2018 Aug; 37(35):4809-4820. PubMed ID: 29769618
[TBL] [Abstract][Full Text] [Related]
25. Aurora-A/SOX8/FOXK1 signaling axis promotes chemoresistance via suppression of cell senescence and induction of glucose metabolism in ovarian cancer organoids and cells.
Sun H; Wang H; Wang X; Aoki Y; Wang X; Yang Y; Cheng X; Wang Z; Wang X
Theranostics; 2020; 10(15):6928-6945. PubMed ID: 32550913
[No Abstract] [Full Text] [Related]
26. Inhibition of mitochondrial translation as a therapeutic strategy for human ovarian cancer to overcome chemoresistance.
Hu B; Guo Y
Biochem Biophys Res Commun; 2019 Feb; 509(2):373-378. PubMed ID: 30591219
[TBL] [Abstract][Full Text] [Related]
27. PGC1α and VDAC1 expression in endometrial cancer.
Wersäll OC; Löfstedt L; Govorov I; Mints M; Gabrielson M; Shoshan M
Mol Clin Oncol; 2021 Feb; 14(2):42. PubMed ID: 33437480
[TBL] [Abstract][Full Text] [Related]
28. Direct impact of cisplatin on mitochondria induces ROS production that dictates cell fate of ovarian cancer cells.
Kleih M; Böpple K; Dong M; Gaißler A; Heine S; Olayioye MA; Aulitzky WE; Essmann F
Cell Death Dis; 2019 Nov; 10(11):851. PubMed ID: 31699970
[TBL] [Abstract][Full Text] [Related]
29. The role of calcium in VDAC1 oligomerization and mitochondria-mediated apoptosis.
Keinan N; Pahima H; Ben-Hail D; Shoshan-Barmatz V
Biochim Biophys Acta; 2013 Jul; 1833(7):1745-54. PubMed ID: 23542128
[TBL] [Abstract][Full Text] [Related]
30. Trichostatin A up-regulates p73 and induces Bax-dependent apoptosis in cisplatin-resistant ovarian cancer cells.
Muscolini M; Cianfrocca R; Sajeva A; Mozzetti S; Ferrandina G; Costanzo A; Tuosto L
Mol Cancer Ther; 2008 Jun; 7(6):1410-9. PubMed ID: 18566213
[TBL] [Abstract][Full Text] [Related]
31. "Metabolic reprogramming" in ovarian cancer cells resistant to cisplatin.
Montopoli M; Bellanda M; Lonardoni F; Ragazzi E; Dorigo P; Froldi G; Mammi S; Caparrotta L
Curr Cancer Drug Targets; 2011 Feb; 11(2):226-35. PubMed ID: 21158717
[TBL] [Abstract][Full Text] [Related]
32. Akt-mediated cisplatin resistance in ovarian cancer: modulation of p53 action on caspase-dependent mitochondrial death pathway.
Yang X; Fraser M; Moll UM; Basak A; Tsang BK
Cancer Res; 2006 Mar; 66(6):3126-36. PubMed ID: 16540663
[TBL] [Abstract][Full Text] [Related]
33. PGC1α/β Expression Predicts Therapeutic Response to Oxidative Phosphorylation Inhibition in Ovarian Cancer.
Ghilardi C; Moreira-Barbosa C; Brunelli L; Ostano P; Panini N; Lupi M; Anastasia A; Fiordaliso F; Salio M; Formenti L; Russo M; Arrigoni E; Chiaradonna F; Chiorino G; Draetta G; Marszalek JR; Vellano CP; Pastorelli R; Bani M; Decio A; Giavazzi R
Cancer Res; 2022 Apr; 82(7):1423-1434. PubMed ID: 35131872
[TBL] [Abstract][Full Text] [Related]
34. Overcoming cisplatin resistance of ovarian cancer cells by targeting HIF-1-regulated cancer metabolism.
Ai Z; Lu Y; Qiu S; Fan Z
Cancer Lett; 2016 Apr; 373(1):36-44. PubMed ID: 26801746
[TBL] [Abstract][Full Text] [Related]
35. The Voltage-dependent Anion Channel 1 Mediates Amyloid β Toxicity and Represents a Potential Target for Alzheimer Disease Therapy.
Smilansky A; Dangoor L; Nakdimon I; Ben-Hail D; Mizrachi D; Shoshan-Barmatz V
J Biol Chem; 2015 Dec; 290(52):30670-83. PubMed ID: 26542804
[TBL] [Abstract][Full Text] [Related]
36. Kaempferol impairs aerobic glycolysis against melanoma metastasis via inhibiting the mitochondrial binding of HK2 and VDAC1.
Zheng X; Pan Y; Yang G; Liu Y; Zou J; Zhao H; Yin G; Wu Y; Li X; Wei Z; Yu S; Zhao Y; Wang A; Chen W; Lu Y
Eur J Pharmacol; 2022 Sep; 931():175226. PubMed ID: 36007607
[TBL] [Abstract][Full Text] [Related]
37. Clinical implication of voltage-dependent anion channel 1 in uterine cervical cancer and its action on cervical cancer cells.
Wu CH; Lin YW; Wu TF; Ko JL; Wang PH
Oncotarget; 2016 Jan; 7(4):4210-25. PubMed ID: 26716410
[TBL] [Abstract][Full Text] [Related]
38. Characterization of mitochondria in cisplatin-resistant human ovarian carcinoma cells.
Hirama M; Isonishi S; Yasuda M; Ishikawa H
Oncol Rep; 2006 Nov; 16(5):997-1002. PubMed ID: 17016583
[TBL] [Abstract][Full Text] [Related]
39. Quinocetone induces mitochondrial apoptosis in HepG2 cells through ROS-dependent promotion of VDAC1 oligomerization and suppression of Wnt1/β-catenin signaling pathway.
Yang X; Tang S; Dai C; Li D; Zhang S; Deng S; Zhou Y; Xiao X
Food Chem Toxicol; 2017 Jul; 105():161-176. PubMed ID: 28343033
[TBL] [Abstract][Full Text] [Related]
40. Mortalin-mediated and ERK-controlled targeting of HIF-1α to mitochondria confers resistance to apoptosis under hypoxia.
Mylonis I; Kourti M; Samiotaki M; Panayotou G; Simos G
J Cell Sci; 2017 Jan; 130(2):466-479. PubMed ID: 27909249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
